Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Cholangiocarcinoma | Research

Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma

Authors: Hui Xie, Tao Hong, Wencai Liu, Xiaodong Jia, Le Wang, Huan Zhang, Chan Xu, Xiaoke Zhang, Wen-Le Li, Quan Wang, Chengliang Yin, Xu Lv

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Objective

Prediction of lymph node metastasis (LNM) for intrahepatic cholangiocarcinoma (ICC) is critical for the treatment regimen and prognosis. We aim to develop and validate machine learning (ML)-based predictive models for LNM in patients with ICC.

Methods

A total of 345 patients with clinicopathological characteristics confirmed ICC from Jan 2007 to Jan 2019 were enrolled. The predictors of LNM were identified by the least absolute shrinkage and selection operator (LASSO) and logistic analysis. The selected variables were used for developing prediction models for LNM by six ML algorithms, including Logistic regression (LR), Gradient boosting machine (GBM), Extreme gradient boosting (XGB), Random Forest (RF), Decision tree (DT), Multilayer perceptron (MLP). We applied 10-fold cross validation as internal validation and calculated the average of the areas under the receiver operating characteristic (ROC) curve to measure the performance of all models. A feature selection approach was applied to identify importance of predictors in each model. The heat map was used to investigate the correlation of features. Finally, we established a web calculator using the best-performing model.

Results

In multivariate logistic regression analysis, factors including alcoholic liver disease (ALD), smoking, boundary, diameter, and white blood cell (WBC) were identified as independent predictors for LNM in patients with ICC. In internal validation, the average values of AUC of six models ranged from 0.820 to 0.908. The XGB model was identified as the best model, the average AUC was 0.908. Finally, we established a web calculator by XGB model, which was useful for clinicians to calculate the likelihood of LNM.

Conclusion

The proposed ML-based predicted models had a good performance to predict LNM of patients with ICC. XGB performed best. A web calculator based on the ML algorithm showed promise in assisting clinicians to predict LNM and developed individualized medical plans.
Literature
1.
go back to reference Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–89.PubMedCrossRef Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–89.PubMedCrossRef
2.
go back to reference Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K, Sahara K, Bagante F, Beal EW, Shen F, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the usa: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–87.PubMedCrossRef Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K, Sahara K, Bagante F, Beal EW, Shen F, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the usa: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–87.PubMedCrossRef
3.
go back to reference Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, et al. Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2021;25(5):1156–63.PubMedCrossRef Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, et al. Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2021;25(5):1156–63.PubMedCrossRef
4.
go back to reference Yeesoonsang S, McNeil E, Virani S, Bilheem S, Pittayawonganon C, Jiraphongsa C, Sriplung H. Trends in incidence of two major subtypes of liver and bile duct cancer: hepatocellular carcinoma and cholangiocarcinoma in songkhla, southern thailand, 1989–2030. J Cancer Epidemiol. 2018;2018:8267059.PubMedPubMedCentralCrossRef Yeesoonsang S, McNeil E, Virani S, Bilheem S, Pittayawonganon C, Jiraphongsa C, Sriplung H. Trends in incidence of two major subtypes of liver and bile duct cancer: hepatocellular carcinoma and cholangiocarcinoma in songkhla, southern thailand, 1989–2030. J Cancer Epidemiol. 2018;2018:8267059.PubMedPubMedCentralCrossRef
5.
go back to reference West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer. 2006;94(11):1751–8.PubMedPubMedCentralCrossRef West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer. 2006;94(11):1751–8.PubMedPubMedCentralCrossRef
6.
go back to reference Amini N, Spolverato G, Kim Y, Gupta R, Margonis GA, Ejaz A, Pawlik TM. Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems. J Surg Oncol. 2015;111(3):299–305.PubMedCrossRef Amini N, Spolverato G, Kim Y, Gupta R, Margonis GA, Ejaz A, Pawlik TM. Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems. J Surg Oncol. 2015;111(3):299–305.PubMedCrossRef
7.
go back to reference Yamaoka R, Ishii T, Kawai T, Yasuchika K, Miyauchi Y, Kojima H, Katayama H, Ogiso S, Fukumitsu K, Uemoto S. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis. J Surg Oncol. 2018;118(4):664–74.PubMedCrossRef Yamaoka R, Ishii T, Kawai T, Yasuchika K, Miyauchi Y, Kojima H, Katayama H, Ogiso S, Fukumitsu K, Uemoto S. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis. J Surg Oncol. 2018;118(4):664–74.PubMedCrossRef
8.
go back to reference Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K, Yasuchika K, Uemoto S. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2018;25(6):299–307.PubMedCrossRef Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K, Yasuchika K, Uemoto S. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2018;25(6):299–307.PubMedCrossRef
9.
go back to reference Ji GW, Zhu FP, Zhang YD, Liu XS, Wu FY, Wang K, Xia YX, Zhang YD, Jiang WJ, Li XC, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol. 2019;29(7):3725–35.PubMedCrossRef Ji GW, Zhu FP, Zhang YD, Liu XS, Wu FY, Wang K, Xia YX, Zhang YD, Jiang WJ, Li XC, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol. 2019;29(7):3725–35.PubMedCrossRef
10.
go back to reference Adachi T, Eguchi S. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date. J Hepatobiliary Pancreat Sci. 2014;21(3):162–8.PubMedCrossRef Adachi T, Eguchi S. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date. J Hepatobiliary Pancreat Sci. 2014;21(3):162–8.PubMedCrossRef
11.
go back to reference Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis M, et al. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg. 2012;147(12):1107–13.PubMedCrossRef Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis M, et al. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg. 2012;147(12):1107–13.PubMedCrossRef
12.
go back to reference Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, Sahani DV. Cholangiocarcinoma: Current and Novel Imaging Techniques. Radiographics. 2008;28(5):1263–87.PubMedCrossRef Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, Sahani DV. Cholangiocarcinoma: Current and Novel Imaging Techniques. Radiographics. 2008;28(5):1263–87.PubMedCrossRef
13.
go back to reference Hu JH, Tang JH, Lin CH, Chu YY, Liu NJ. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. J Investig Med. 2018;66(1):52–61.PubMedCrossRef Hu JH, Tang JH, Lin CH, Chu YY, Liu NJ. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. J Investig Med. 2018;66(1):52–61.PubMedCrossRef
14.
go back to reference Nam K, Hwang DW, Shim JH, Song TJ, Lee SS, Seo DW, Lee SK, Kim MH, Kim KH, Hwang S, et al. Novel preoperative nomogram for prediction of futile resection in patients undergoing exploration for potentially resectable intrahepatic cholangiocarcinoma. Sci Rep. 2017;7:42954.PubMedPubMedCentralCrossRef Nam K, Hwang DW, Shim JH, Song TJ, Lee SS, Seo DW, Lee SK, Kim MH, Kim KH, Hwang S, et al. Novel preoperative nomogram for prediction of futile resection in patients undergoing exploration for potentially resectable intrahepatic cholangiocarcinoma. Sci Rep. 2017;7:42954.PubMedPubMedCentralCrossRef
15.
go back to reference Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg. 2014;149(5):432–8.PubMedCrossRef Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg. 2014;149(5):432–8.PubMedCrossRef
16.
go back to reference Navarro JG, Lee JH, Kang I, Rho SY, Choi GH, Han DH, Kim KS, Choi JS. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection? HPB (Oxford). 2020;22(10):1411–9.PubMedCrossRef Navarro JG, Lee JH, Kang I, Rho SY, Choi GH, Han DH, Kim KS, Choi JS. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection? HPB (Oxford). 2020;22(10):1411–9.PubMedCrossRef
17.
go back to reference Zhu Y, Mao Y, Chen J, Qiu Y, Wang Z, He J. Preoperative computed tomography features of intrahepatic cholangiocarcinoma for predicting lymph node metastasis and overall survival. J Comput Assist Tomogr. 2019;43(5):729–35.PubMedCrossRef Zhu Y, Mao Y, Chen J, Qiu Y, Wang Z, He J. Preoperative computed tomography features of intrahepatic cholangiocarcinoma for predicting lymph node metastasis and overall survival. J Comput Assist Tomogr. 2019;43(5):729–35.PubMedCrossRef
18.
go back to reference Yamada T, Nakanishi Y, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Tanaka K, Kurashima Y. Ebihara Y et al: Impact of serum carbohydrate antigen 19–9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol. 2018;33(9):1626–33.CrossRef Yamada T, Nakanishi Y, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Tanaka K, Kurashima Y. Ebihara Y et al: Impact of serum carbohydrate antigen 19–9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol. 2018;33(9):1626–33.CrossRef
19.
go back to reference Meng ZW, Lin XQ, Zhu JH, Han SH, Chen YL. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma. J Surg Res. 2018;226:56–63.PubMedCrossRef Meng ZW, Lin XQ, Zhu JH, Han SH, Chen YL. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma. J Surg Res. 2018;226:56–63.PubMedCrossRef
20.
go back to reference Chen YX, Zeng ZC, Tang ZY, Fan J, Zhou J, Jiang W, Zeng MS, Tan YS. Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases. Front Oncol. 2011;1:42.PubMedPubMedCentralCrossRef Chen YX, Zeng ZC, Tang ZY, Fan J, Zhou J, Jiang W, Zeng MS, Tan YS. Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases. Front Oncol. 2011;1:42.PubMedPubMedCentralCrossRef
21.
go back to reference Zhu J, Zheng J, Li L, Huang R, Ren H, Wang D, Dai Z, Su X. Application of machine learning algorithms to predict central lymph node metastasis in T1–T2, non-invasive, and clinically node negative papillary thyroid carcinoma. Front Med (Lausanne). 2021;8:635771.PubMedCrossRef Zhu J, Zheng J, Li L, Huang R, Ren H, Wang D, Dai Z, Su X. Application of machine learning algorithms to predict central lymph node metastasis in T1–T2, non-invasive, and clinically node negative papillary thyroid carcinoma. Front Med (Lausanne). 2021;8:635771.PubMedCrossRef
22.
go back to reference Kwak MS, Eun YG, Lee JW, Lee YC. Development of a machine learning model for the prediction of nodal metastasis in early T classification oral squamous cell carcinoma: SEER-based population study. Head Neck. 2021;43(8):2316–24.PubMedCrossRef Kwak MS, Eun YG, Lee JW, Lee YC. Development of a machine learning model for the prediction of nodal metastasis in early T classification oral squamous cell carcinoma: SEER-based population study. Head Neck. 2021;43(8):2316–24.PubMedCrossRef
23.
go back to reference Liu WC, Li ZQ, Luo ZW, Liao WJ, Liu ZL, Liu JM. Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer. Cancer Med. 2021;10(8):2802–11.PubMedPubMedCentralCrossRef Liu WC, Li ZQ, Luo ZW, Liao WJ, Liu ZL, Liu JM. Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer. Cancer Med. 2021;10(8):2802–11.PubMedPubMedCentralCrossRef
24.
go back to reference Wen J, Pan T, Yuan YC, Huang QS, Shen J. Nomogram to predict postoperative infectious complications after surgery for colorectal cancer: a retrospective cohort study in China. World J Surg Oncol. 2021;19(1):204.PubMedPubMedCentralCrossRef Wen J, Pan T, Yuan YC, Huang QS, Shen J. Nomogram to predict postoperative infectious complications after surgery for colorectal cancer: a retrospective cohort study in China. World J Surg Oncol. 2021;19(1):204.PubMedPubMedCentralCrossRef
25.
go back to reference Cai J, Luo J, Wang S, Yang S. Feature selection in machine learning: a new perspective. Neurocomputing. 2018;300:70–9.CrossRef Cai J, Luo J, Wang S, Yang S. Feature selection in machine learning: a new perspective. Neurocomputing. 2018;300:70–9.CrossRef
26.
go back to reference Gonzalez GH, Tahsin T, Goodale BC, Greene AC, Greene CS. Recent advances and emerging applications in text and data mining for biomedical discovery. Brief Bioinform. 2016;17(1):33–42.PubMedCrossRef Gonzalez GH, Tahsin T, Goodale BC, Greene AC, Greene CS. Recent advances and emerging applications in text and data mining for biomedical discovery. Brief Bioinform. 2016;17(1):33–42.PubMedCrossRef
27.
go back to reference Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. The Lancet Oncology. 2019;20(5):e262–73.PubMedCrossRef Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. The Lancet Oncology. 2019;20(5):e262–73.PubMedCrossRef
28.
go back to reference Wu TT, Yang DL, Li H, Guo YS. Development and validation of a nomogram to predict in-hospital cardiac arrest among patients admitted with acute coronary syndrome. Am J Emerg Med. 2021;49:240–8.PubMedCrossRef Wu TT, Yang DL, Li H, Guo YS. Development and validation of a nomogram to predict in-hospital cardiac arrest among patients admitted with acute coronary syndrome. Am J Emerg Med. 2021;49:240–8.PubMedCrossRef
29.
go back to reference Ohtsuka M, Ito H, Kimura F, Togawa A, Yoshidome H, Miyazaki M. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89(12):1525–31.PubMedCrossRef Ohtsuka M, Ito H, Kimura F, Togawa A, Yoshidome H, Miyazaki M. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89(12):1525–31.PubMedCrossRef
30.
go back to reference Vitale A, Moustafa M, Spolverato G, Gani F, Cillo U, Pawlik TM. Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2016;113(6):685–91.PubMedCrossRef Vitale A, Moustafa M, Spolverato G, Gani F, Cillo U, Pawlik TM. Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2016;113(6):685–91.PubMedCrossRef
31.
go back to reference Yamashita Y, Taketomi A, Morita K, Fukuhara T, Ueda S, Sanefuji K, Iguchi T, Kayashima H, Sugimachi K, Maehara Y. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res. 2008;28(4C):2353–9. Yamashita Y, Taketomi A, Morita K, Fukuhara T, Ueda S, Sanefuji K, Iguchi T, Kayashima H, Sugimachi K, Maehara Y. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res. 2008;28(4C):2353–9.
32.
go back to reference Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):669–80.PubMedCrossRef Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):669–80.PubMedCrossRef
33.
go back to reference Ruzzenente A, Conci S, Vigano L, Ercolani G, Manfreda S, Bagante F, Ciangherotti A, Pedrazzani C, Pinna AD, Iacono C, et al. Role of lymph node dissection in small (≤ 3 cm) intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2019;23(6):1122–9.PubMedCrossRef Ruzzenente A, Conci S, Vigano L, Ercolani G, Manfreda S, Bagante F, Ciangherotti A, Pedrazzani C, Pinna AD, Iacono C, et al. Role of lymph node dissection in small (≤ 3 cm) intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2019;23(6):1122–9.PubMedCrossRef
34.
go back to reference Uchiyama K, Yamamoto M, Yamaue H, Ariizumi S, Aoki T, Kokudo N, Ebata T, Nagino M, Ohtsuka M, Miyazaki M, et al. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2011;18(3):443–52.PubMedCrossRef Uchiyama K, Yamamoto M, Yamaue H, Ariizumi S, Aoki T, Kokudo N, Ebata T, Nagino M, Ohtsuka M, Miyazaki M, et al. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2011;18(3):443–52.PubMedCrossRef
35.
go back to reference Chang M-E, Lei H-J, Chen M-H, Yeh Y-C, Li C-P, Hung Y-P, Hsia C-Y, Liu C-A, Chau G-Y, Chao Y. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. J Chin Med Assoc. 2017;80(3):140–6.PubMedCrossRef Chang M-E, Lei H-J, Chen M-H, Yeh Y-C, Li C-P, Hung Y-P, Hsia C-Y, Liu C-A, Chau G-Y, Chao Y. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. J Chin Med Assoc. 2017;80(3):140–6.PubMedCrossRef
36.
go back to reference Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, et al. Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg. 2015;221(6):1031-1040.e1-4.PubMedCrossRef Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, et al. Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg. 2015;221(6):1031-1040.e1-4.PubMedCrossRef
37.
go back to reference Shirono T, Niizeki T, Iwamoto H, Shimose S, Suzuki H, Kawaguchi T, Kamachi N, Noda Y, Okamura S, Nakano M, et al. Therapeutic outcomes and prognostic factors of unresectable intrahepatic cholangiocarcinoma: a data mining analysis. J Clin Med. 2021;10(5):987.PubMedPubMedCentralCrossRef Shirono T, Niizeki T, Iwamoto H, Shimose S, Suzuki H, Kawaguchi T, Kamachi N, Noda Y, Okamura S, Nakano M, et al. Therapeutic outcomes and prognostic factors of unresectable intrahepatic cholangiocarcinoma: a data mining analysis. J Clin Med. 2021;10(5):987.PubMedPubMedCentralCrossRef
38.
go back to reference Kawai M, Hirono S, Okada KI, Miyazawa M, Shimizu A, Kitahata Y, Kobayashi R, Ueno M, Hayami S, Tanioka K, et al. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer. Surgery. 2019;165(6):1151–60.PubMedCrossRef Kawai M, Hirono S, Okada KI, Miyazawa M, Shimizu A, Kitahata Y, Kobayashi R, Ueno M, Hayami S, Tanioka K, et al. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer. Surgery. 2019;165(6):1151–60.PubMedCrossRef
39.
go back to reference Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.PubMedPubMedCentralCrossRef Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.PubMedPubMedCentralCrossRef
40.
go back to reference Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, McGrath MS, Wongkham S. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol. 2010;161(3):471–9.PubMedPubMedCentralCrossRef Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, McGrath MS, Wongkham S. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol. 2010;161(3):471–9.PubMedPubMedCentralCrossRef
41.
go back to reference Hu RJ, Ma JY, Hu G. Lymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysis. Clin Chim Acta. 2018;481:142–6.PubMedCrossRef Hu RJ, Ma JY, Hu G. Lymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysis. Clin Chim Acta. 2018;481:142–6.PubMedCrossRef
42.
go back to reference Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24(2):330–40.PubMedCrossRef Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24(2):330–40.PubMedCrossRef
43.
go back to reference Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Yoshizumi T, Shirabe K. Absolute neutrophil count predicts postoperative prognosis in mass-forming intrahepatic cholangiocarcinoma. Anticancer Res. 2019;39(2):941–7.PubMedCrossRef Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Yoshizumi T, Shirabe K. Absolute neutrophil count predicts postoperative prognosis in mass-forming intrahepatic cholangiocarcinoma. Anticancer Res. 2019;39(2):941–7.PubMedCrossRef
44.
go back to reference Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, et al. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery. 2018;164(3):411–8.PubMedCrossRef Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, et al. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery. 2018;164(3):411–8.PubMedCrossRef
45.
go back to reference Bi AH, Zeng ZC, Ji Y, Zeng HY, Xu C, Tang ZY, Fan J, Zhou J, Zeng MS, Tan YS. Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. Int J Radiat Oncol Biol Phys. 2010;78(5):1427–36.PubMedCrossRef Bi AH, Zeng ZC, Ji Y, Zeng HY, Xu C, Tang ZY, Fan J, Zhou J, Zeng MS, Tan YS. Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. Int J Radiat Oncol Biol Phys. 2010;78(5):1427–36.PubMedCrossRef
46.
go back to reference Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69–76.PubMedPubMedCentralCrossRef Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69–76.PubMedPubMedCentralCrossRef
47.
go back to reference Xiong J, Yin Z, Xu W, Shen Z, Li Y, Lu X. Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis. OncoTargets and therapy. 2018;11:8211–9.PubMedPubMedCentralCrossRef Xiong J, Yin Z, Xu W, Shen Z, Li Y, Lu X. Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis. OncoTargets and therapy. 2018;11:8211–9.PubMedPubMedCentralCrossRef
48.
go back to reference Petrick JL, Campbell PT, Koshiol J, Thistle JE, Andreotti G, Beane-Freeman LE, Buring JE, Chan AT, Chong DQ, Doody MM, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005–12.PubMedPubMedCentralCrossRef Petrick JL, Campbell PT, Koshiol J, Thistle JE, Andreotti G, Beane-Freeman LE, Buring JE, Chan AT, Chong DQ, Doody MM, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005–12.PubMedPubMedCentralCrossRef
50.
go back to reference El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 Suppl 1):S27-34.PubMedCrossRef El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 Suppl 1):S27-34.PubMedCrossRef
51.
go back to reference Shiels MS, O’Brien TR. Recent decline in hepatocellular carcinoma rates in the united states. Gastroenterology. 2020;158(5):1503-1505.e1502.PubMedCrossRef Shiels MS, O’Brien TR. Recent decline in hepatocellular carcinoma rates in the united states. Gastroenterology. 2020;158(5):1503-1505.e1502.PubMedCrossRef
52.
go back to reference Ye J, Hua M, Zhu F. Machine learning algorithms are superior to conventional regression models in predicting risk stratification of COVID-19 patients. Risk Manag Healthc Policy. 2021;14:3159–66.PubMedPubMedCentralCrossRef Ye J, Hua M, Zhu F. Machine learning algorithms are superior to conventional regression models in predicting risk stratification of COVID-19 patients. Risk Manag Healthc Policy. 2021;14:3159–66.PubMedPubMedCentralCrossRef
Metadata
Title
Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma
Authors
Hui Xie
Tao Hong
Wencai Liu
Xiaodong Jia
Le Wang
Huan Zhang
Chan Xu
Xiaoke Zhang
Wen-Le Li
Quan Wang
Chengliang Yin
Xu Lv
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03223-w

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.